After a sell-out 2022 event, the Lab of the Future Congress USA returns to Boston on the 9th and 10th March 2023. This year the experience comes from the Renaissance Boston Waterfront, a larger venue that supports the continued growth of the Congress.
The annual conference focuses on the latest trends in laboratory digital transformation, and attracts key professionals, scientists, researchers, engineers, and Life Science CIOs from a wide spectrum of industries including biopharmaceutical, technology, healthcare, government, and academia.
AgiLab are proud sponsors of the event which will be attended by hundreds of life science research leaders in the most popular congress supporting biopharma R&D.
Over the two-day Congress industry leading professionals will discuss every aspect of biopharma R&D from powering drug discovery through data science to the integration and development of diverse technologies.
Anahita Laskowski, AgiLab’s Head of Sales, joins the prestigious line-up of speakers on Sunday to discuss the connected lab in her session “Empowering Scientists with an Enterprise Laboratory Platform”. Exploring AgiLab’s unique holistic approach to the digital transformation of the complete lab philosophy and process, Anahita will discuss everything life sciences need to succeed in pursuing lab of the future projects.
Innovative industries need to go beyond what singular Laboratory Information Management System (LIMS), Electronic Laboratory Notebook (ELN) and Laboratory Execution System (LES) applications of the past have done. AgiLab provides more by combining the latest technologies to offer a truly unified laboratory digital foundation for data management across the entire product value chain.
We invite you to join Anahita at 13:40 on Sunday 10th March. Material from her presentation will be available after the Congress, so make sure you bookmark the AgiLab news channel for further details.
Register for The Lab of the Future USA and get your delegate pass, standard passes and not for profit passes are available.